N NEXT & BIO
LIVE

Serial Number

98259147

Owner

KOLMAR KOREA HOLDINGS CO., LTD.

Attorney

James J. Saul

Filing Date

Nov 7, 2023

Add to watchlist:

No watchlists yet
View on USPTO

N NEXT & BIO Trademark

Serial Number: 98259147 • Registration: 7954437

N NEXT & BIO is a trademark filed by KOLMAR KOREA HOLDINGS CO., LTD. on November 7, 2023. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

KOLMAR KOREA HOLDINGS CO., LTD. (61 trademarks)

12-11, Deokgogae-gil,
Sejong-si 30004 , KR

Entity Type: 03

KOLMAR HOLDINGS CO., LTD. (57 trademarks)

12-11, DEOKGOGAE-GIL
SEJONG-SI 30004 , KR

Entity Type: 03

Trademark Details

Filing Date

November 7, 2023

Registration Date

September 23, 2025

Published for Opposition

August 5, 2025

Goods & Services

Biological preparations for use in cell cultures for medical purposes, namely, for use in biotechnology for the treatment of cancer, infectious diseases, metabolic diseases and disorders; vaccines; reagents for medical use; medical diagnostic reagents; diagnostic preparations for medical purposes; pharmaceutical preparations for diagnosis for medical purposes; chemico-pharmaceutical preparations for the treatment of central nervous system diseases, cancer and metabolic diseases; chemico-pharmaceutical preparations, namely, chemical preparations for pharmaceutical or medical purposes; nutritional supplements; Veterinary preparations and substances for treating infections and inflammation; vitamin drops

Development of biologics; scientific research in the field of pharmacy; scientific research in the fields of medicine, health and pharmacology; scientific research and testing services in the nature of chemical screening analysis for drug discovery for scientific research purposes; Platform as a Service featuring computer software platforms for screening new pharmaceuticals and precision medicine; conducting early evaluations in the field of new pharmaceuticals; drug discovery services; medical research laboratory services; Software as a service featuring software for analyzing data, database management, and accounting related to drug discovery; Platform as a Service featuring software for analyzing data, database management, and accounting in the fields of medicine, health and pharmacology

Medical analysis services for the diagnosis of cancer; medical services, namely, analysis of human tissues for medical treatment; medical analysis for the diagnosis and treatment of persons; medical services, namely, analysis of human biodata for medical purposes; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical screening; medical examination services; information services relating to medical products for treatment and medical purposes; medical information

Biological preparations for use in industry and science, other than for medical or veterinary purposes; cells for scientific or laboratory purposes; cultures of microorganisms for scientific or laboratory purposes, other than for medical and veterinary use; preparations of microorganisms, other than for medical and veterinary use; bacterial preparations, other than for medical and veterinary use; bacteria for use in food manufacture; probiotic bacterial cultures for use in the manufacture of food supplements in the food industry; diagnostic reagents, other than for medical or veterinary purposes; reagents for medical research; chemical preparations in the nature of chemical additives for use in the manufacture of pharmaceuticals

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Sep 23, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Sep 23, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 5, 2025 NPUB
PUBLISHED FOR OPPOSITION
Aug 5, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 30, 2025 NONP
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Jul 4, 2025 ERRR
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 16, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 15, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 15, 2025 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Apr 15, 2025 ERSI
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Mar 23, 2025 RCSC
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Feb 10, 2025 RCCK
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Dec 10, 2024 CHAN
ASSIGNED TO LIE
Dec 10, 2024 ALIE
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Nov 3, 2024 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 3, 2024 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Nov 3, 2024 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 3, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 3, 2024 REAP
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jul 21, 2024 GNS3
LETTER OF SUSPENSION E-MAILED
Jul 21, 2024 GNSL
SUSPENSION LETTER WRITTEN
Jul 21, 2024 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 10, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 10, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 10, 2024 TROA
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Jun 6, 2024 ASGN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 12, 2024 GNRN
NON-FINAL ACTION E-MAILED
Mar 12, 2024 GNRT
NON-FINAL ACTION WRITTEN
Mar 12, 2024 CNRT
ASSIGNED TO EXAMINER
Feb 24, 2024 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Dec 7, 2023 MDSM
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 6, 2023 NWOS
NEW APPLICATION ENTERED
Nov 10, 2023 NWAP